Parallel Advisors’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
GIM
PAI
GCM
Parallel Advisors's BLUE Position: Q4 2023 in Review
Parallel Advisors held its bluebird bio (BLUE) position steady in Q4 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3345.
Parallel Advisors first reported a position in BLUE in Q2 2017 and has held it in 21 quarters since. The position peaked at $14K in Q3 2020. 187 funds tracked by Wall St. Rank hold BLUE as of Q4 2023.
- Parallel Advisors held 0 shares of bluebird bio worth $0 as of Q4 2023.
- Parallel Advisors left its bluebird bio share count unchanged in Q4 2023.
- bluebird bio made up ﹤0.01% of Parallel Advisors's portfolio in Q4 2023, its #3345 holding.
- Parallel Advisors first reported a position in bluebird bio in Q2 2017 and has held it in 21 quarters since.
- Parallel Advisors's bluebird bio position peaked at $14K in Q3 2020.
- 187 funds tracked by Wall St. Rank held bluebird bio as of Q4 2023.
Based on Parallel Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.